Rosario, Argentina

Centro Respiratorio Infantil

Asthma

Dermatitis

Eczema

Atopic Dermatitis

Lebrikizumab

Povorcitinib

Roche

AbbVie

Incyte

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Centro Respiratorio Infantil | Rosario, Argentina

Site insights

Work at this site?

Active trials

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Trial sponsors